Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?
- 19 July 2011
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 45 (5) , 339-345
Abstract
Brachytherapy has good results in the treatment of early prostate cancer (PC). The procedure is challenging in large prostates, and the optimal prostate volume for brachytherapy was previously defined as ≤40 ml. This study analysed the outcome of PC patients with small (group A) and large (group B) prostate volume in prospective data. The material consisted of 535 consecutive patients treated with brachytherapy in Kuopio University Hospital. The mean follow-up time was nearly 6 years. Prostate-specific antigen (PSA) failure was defined as PSA rising ≥2.0 μg/l above nadir. A PSA bounce was defined as a rise in PSA of ≥0.2 μg/l. The causes of death were recorded. A bounce was recorded more frequently in group A (30%) than in group B (18%) (p = 0.006). A bounce correlated with young age predicted a favourable outcome in both groups. PSA failure rate was similar in both groups: 13% and 12% in groups A and B, respectively. Post-treatment PSA ≤0.5 μg/l was the only independent prognostic factor associated with PSA failure in both groups (p < 0.0001, both groups). PC survival was 98.4% in both groups. Overall survival was 91% and 94% in groups A and B, respectively (p = not significant). There were no differences between the PC patients with small and large prostate volumes treated with brachytherapy with respect to PSA failure rate, PC survival or overall survival. All patients, independent of prostate size, are potential candidates for brachytherapy.Keywords
This publication has 20 references indexed in Scilit:
- Comparative 5-year outcomes of brachytherapy and surgery for prostate cancerBrachytherapy, 2011
- Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective studyWorld Journal of Urology, 2009
- Selecting Patients for Exclusive Permanent Implant Prostate Brachytherapy: The Experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital Group on 809 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Preimplant Predictive Factors of Urinary Retention After Iodine 125 Prostate BrachytherapyUrology, 2007
- Dynamic dose‐feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantationBJU International, 2007
- PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: A study of 295 patients with a minimum 3-year followupBrachytherapy, 2006
- PROSTATE CANCER IN A LARGE PROSTATE IS ASSOCIATED WITH A DECREASED PROSTATE SPECIFIC ANTIGEN FAILURE RATE AFTER BRACHYTHERAPYJournal of Urology, 2005
- Brachytherapy for Prostate Cancer: A Systematic Review of Clinical and Cost EffectivenessEuropean Urology, 2003
- Prostate Cancer With Large Glands Treated With 3-Dimensional Computerized Tomography Guided Pararectal Brachytherapy: Up to 8 Years of FollowupJournal of Urology, 2003
- ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancerRadiotherapy and Oncology, 2000